Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 909-586-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The available data suggests that aluminium oxide is unlikely to lead to skin, eye or respiratory irritative effects.
Skin irritation
- Degussa (1979a) [Al2O3, Klimisch=2], similar to OECD TG 404, test substance is not a skin irritant;
-Degussa (1979b) [Al2O3, Klimisch=2], similar to OECD TG 404, test substance is not a skin irritant;
-Cabot (1969a) [Al2O3, Klimisch=2], similar to OECD TG 404, test substance is not a skin irritant;
-LAB Research Ltd., Study 09/164-006N (OECD TG# 404) [Al(OH)3 powder, Klimisch=1], test substance is not a skin irritant
Eye irritation
-Degussa (1979a) [Al2O3, Klimisch=2], FDA of the United States (Fed. Reg. 28 (119), 5582, 1963) Draize and Kelly (Drug Cosmet. Industr. 71 (1952) 36), test substance is not a eye irritant;
-Degussa (1979b) [Al2O3, Klimisch=2], FDA of the United States (Fed. Reg. 28 (119), 5582, 1963) Draize and Kelly (Drug Cosmet. Industr. 71 (1952) 36) test substance is not a eye irritant;
-Cabot (1969a) [Al2O3, Klimisch=2], similar to OECD TG 405, test substance is not a eye irritant;
-LAB Research Ltd., Study 09/164-006N (OECD TG# 405) [Al(OH)3 powder, Klimisch=2], test substance is not a eye irritant
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin irritation:
No human studies were located that examined acute dermal irritation/corrosion effects in workers exposed occupationally to aluminium oxide particulates. Animal studies conducted by Degussa (1979a,b) reported negative results for acute dermal irritation. An animal study that exposed rabbits to aluminium oxide powder in accordance with OECD TG 404 “Acute Dermal Irritation/Corrosion” (1989) provides evidence supporting the absence of dermal irritation effects of aluminium oxide (Aluminium oxide, IUCLID, 2000). A full report of this study is not available.
A pre-guideline study conducted by Cabot (Cabot, 1969a) on Al2O3, a high purity fumed alumina formed by the chemical hydrolysis of aluminium chloride, also reported negative results and contributes to the weight of evidence. The negative results from the LAB Research Ltd. Study (2009) and Lansdown (1973) for aluminium hydroxide also contribute to the weight of evidence that irritative properties of aluminium oxide are unlikely on acute dermal exposure. Overall, the weight of evidence suggests that aluminium oxide dust or powder is unlikely to lead to irritative effects on acute dermal exposure.
Eye irritation:
An animal study conducted according to OECD TG #405 “Acute Eye Irritation/Corrosion” (1989) has provided data supporting the absence of irritation effects of aluminium oxide (Aluminium oxide, IUCLID, 2000). However, the full report of this study is not available. Studies by Degussa (1979a,b) on aluminium oxide and a study by Cabot (1969) on a fumed alumina, also reported negative results. The negative results from the LAB Research Ltd. Study (2009) on aluminium hydroxide also contribute to the weight of evidence for a lack of irritative properties of aluminium oxide on acute eye exposure. Overall, the weight of evidence suggests a lack of chemical irritative properties for aluminium oxide dust on acute eye exposure.
Respiratory irritation:
Human Studies
Results from two studies that examined cross-shift lung effects among aluminium reduction workers (Chan-Yeung et al., 1983; Kilburn and Warshaw, 1989) provide insufficient evidence for an acute, irritative, substance-specific effect from inhalation of aluminium oxide particulates in this occupational setting.
Airborne exposures in the potroom are multiple – several of which may contribute to a pulmonary response. The evidence suggests a role for aluminium fluoride (AlF3), cryolite
(Na4AlF6), or hydrogen fluoride (HF) in the causation of observed lung effects (ATSDR, 2008; Krewski et al., 2007; Sorgdrager et al., 1995; Soyseth and Kongerud, 1992; Kongerud, 1992). Co-exposure to nickel and the extremely high, accidental exposure levels cannot be excluded as contributory to the toxic pneumonia and fibrosis found in a thermal sprayer (20% aluminium and 80% nickel metal content; Schaller et al., 2007). Results from three studies that examined cross-shift lung effects among aluminium-exposed welders (Kilburn et al., 1989; Fishwick et al., 2004; Gube et al., 2009) provide insufficient evidence for an acute, irritative, substance-specific effect from inhalation of aluminium oxide fume.
No studies were located that reported acute lung effects in workers from short-term inhalation exposure to aluminium hydroxide dust. Results from cross-sectional studies among bauxite-exposed workers are inconclusive concerning a respiratory irritative effect associated with the cumulative exposure levels encountered in the workplace (Beach et al., 2001; Fritschi et al. 2001/2003; Townsend et al., 1985, 1988). Threats to the validity of the available studies include possible selection biases due to cross-sectional designs, residual confounding by smoking, possibly irritative co-exposures, and the lack of measurements of the respirable fraction.
Animal Studies
Pauluhn (2009a) observed an inflammatory response in BALF cytology and biochemistry that was mild and to some degree reversible in a subacute study in rats exposed by inhalation to agglomerated nano-sized aluminium oxyhydroxide particulates. The inflammatory response after 10 days of exposure was significant at the highest dose of 28 mg/m³ but was not detectable at 0.4 and 3 mg/m³. Lindenschmidt et al. (1990) administered single doses of 10 and 50 mg/kg bw Al2O3 to Fischer 344 rats by intratracheal instillation (ITI). Responses to crystalline silica and TiO2 were also examined and compared with a saline control. At 50 mg/kg bw, both Al2O3 and TiO2 exhibited early changes in BAL biochemistry and cells consistent with a mild inflammatory response. All values returned to baseline by 9 weeks post-treatment. For the 10 mg/kg bw level, values had returned to normal 2 weeks post-treatment. Tornling et al. (1993) compared BAL biochemistry in Sprague-Dawley rats on single intratracheal instillation of primary or secondary alumina. Only the fluoride-containing secondary alumina exhibited a reversible, short-term inflammatory response. Fibronectin was elevated in both the primary and secondary alumina-treated groups at the end of the study suggesting a role of the alumina component in the development oflonger-term effects. White et al. (1987) compared BAL biochemistry, BAL cell counts, and lung tissue biochemistry in male Fischer 344 rats exposed to virginal alumina or potroom dust in a short-term, single ITI dose study. The effects of the alumina were typical of a nuisance dust with no evidence of an acute inflammatory response.
Summary
Overall, the current evidence for an acute irritative effect on inhalation exposure to aluminium oxide or bauxite from human studies does not support a chemical-specific irritative effect. The evidence from animal studies and in-vitro studies also does not support a chemical-specific irritative effect. Based on the available data, aluminium oxide and aluminium hydroxide dust are low cytotoxicity “nuisance dusts” with mild, respiratory irritant effects on acute exposure.
Justification for classification or non-classification
Acute Skin Irritation
Available data are adequate to conclude that there is no need to recommend Classification and Labelling (2008) requirements for skin irritation from acute exposures to aluminium oxide.
Acute Eye Irritation
Available data are adequate to conclude that there is no need to recommend Classification and Labelling (2008) requirements for eye irritation from acute exposures to aluminium oxide dust or powder.
Acute respiratory irritation:
Overall, the current evidence for an acute irritative effect on inhalation exposure to aluminium oxide or bauxite from human studies does not support a chemical-specific irritative effect. The evidence from animal studies and in-vitro studies also does not support a chemical-specific irritative effect.
Overall, according to DSD (67/548/EEC) or CLP (1272/2008/EC)classification criteria for irritation/corrosion, no classification is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.